Index RUT
P/E 20.09
EPS (ttm) 1.52
Insider Own 0.79%
Shs Outstand 174.58M
Perf Week 2.17%
Market Cap 5.31B
Forward P/E 22.34
EPS next Y 1.37
Insider Trans 2.46%
Shs Float 172.45M
Perf Month -2.89%
Income 272.67M
PEG 2.01
EPS next Q 0.28
Inst Own 98.36%
Short Float 2.50%
Perf Quarter -4.05%
Sales 4.43B
P/S 1.20
EPS this Y -19.96%
Inst Trans 3.09%
Short Ratio 3.22
Perf Half Y 6.82%
Book/sh 8.22
P/B 3.71
EPS next Y 15.39%
ROA 8.55%
Short Interest 4.30M
Perf Year 9.15%
Cash/sh 1.26
P/C 24.18
EPS next 5Y 10.00%
ROE 19.62%
52W Range 26.17 - 35.74
Perf YTD -9.35%
Dividend Est. -
P/FCF 31.07
EPS past 5Y -
ROI 10.59%
52W High -14.55%
Beta 1.33
Dividend TTM -
Quick Ratio 1.39
Sales past 5Y 17.51%
Gross Margin 21.01%
52W Low 16.70%
ATR (14) 0.96
Dividend Ex-Date -
Current Ratio 1.77
EPS Y/Y TTM 74.47%
Oper. Margin 7.15%
RSI (14) 48.42
Volatility 3.13% 3.39%
Employees 5809
Debt/Eq 0.82
Sales Y/Y TTM 9.59%
Profit Margin 6.15%
Recom 1.11
Target Price 39.45
Option/Short Yes / Yes
LT Debt/Eq 0.80
EPS Q/Q 18.83%
Payout 0.00%
Rel Volume 0.39
Prev Close 30.02
Sales Surprise 4.03%
EPS Surprise 15.15%
Sales Q/Q 12.82%
Earnings Apr 23 BMO
Avg Volume 1.34M
Price 30.54
SMA20 0.24%
SMA50 -3.27%
SMA200 -4.84%
Trades
Volume 397,565
Change 1.73%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-27-23 Resumed
Jefferies
Buy
$38
Jul-19-21 Upgrade
Goldman
Neutral → Buy
$20 → $25
Jan-22-21 Initiated
Deutsche Bank
Buy
$22
Jan-11-21 Initiated
JP Morgan
Overweight
$21
Dec-15-20 Initiated
Goldman
Neutral
$18
Jun-24-20 Initiated
BofA/Merrill
Buy
$18
Apr-29-24 04:05PM
Apr-26-24 12:00PM
09:40AM
Apr-25-24 11:27AM
Apr-24-24 03:49AM
(Thomson Reuters StreetEvents)
03:03AM
Loading…
03:03AM
Apr-23-24 11:54AM
08:33AM
08:19AM
08:15AM
07:15AM
(Associated Press Finance)
07:00AM
Apr-22-24 12:10PM
Apr-16-24 10:00AM
Apr-04-24 04:05PM
05:25PM
Loading…
Mar-26-24 05:25PM
Mar-14-24 07:14PM
05:04PM
04:58PM
04:25PM
Mar-07-24 10:07AM
Feb-23-24 12:34PM
Feb-22-24 11:53PM
(Thomson Reuters StreetEvents)
08:20AM
07:31AM
07:24AM
(Associated Press Finance)
07:00AM
Feb-02-24 06:10AM
Jan-22-24 04:05PM
Jan-08-24 07:00AM
05:14AM
Loading…
Dec-19-23 05:14AM
Dec-11-23 04:05PM
Dec-06-23 04:11PM
Nov-07-23 04:05PM
Oct-26-23 09:35AM
Oct-25-23 10:27PM
(Thomson Reuters StreetEvents) -15.49%
07:05PM
09:56AM
08:15AM
07:08AM
(Associated Press Finance)
07:00AM
Oct-20-23 11:47AM
Oct-18-23 12:04PM
Oct-16-23 02:53PM
Oct-02-23 05:56AM
Sep-29-23 03:59PM
08:19AM
Sep-28-23 08:26PM
Sep-27-23 09:24PM
04:05PM
Sep-15-23 09:18AM
Sep-12-23 08:32AM
Sep-08-23 06:23PM
Sep-05-23 07:54AM
Sep-01-23 11:19AM
Aug-31-23 05:00PM
11:40AM
03:34AM
Aug-28-23 09:59AM
Aug-18-23 07:39AM
Aug-14-23 07:03PM
Aug-11-23 09:39AM
Aug-10-23 12:20PM
10:12AM
Aug-03-23 08:06AM
Aug-02-23 07:53AM
07:37AM
Jul-28-23 12:00PM
Jul-27-23 08:25AM
07:20AM
07:00AM
Jul-25-23 05:36AM
Jul-19-23 11:40AM
Jul-06-23 11:22AM
08:00AM
Jun-30-23 01:04PM
Jun-28-23 09:21AM
Jun-27-23 08:18AM
Jun-26-23 01:39PM
(The Wall Street Journal) +5.18%
09:04AM
08:57AM
08:44AM
Jun-21-23 08:00PM
Jun-11-23 03:45AM
Jun-06-23 01:14PM
08:55AM
Jun-05-23 11:40AM
08:31AM
08:25AM
08:13AM
May-23-23 04:05PM
11:53AM
May-18-23 04:05PM
May-05-23 04:05PM
May-04-23 12:29PM
May-03-23 07:35PM
06:27PM
04:53PM
04:31PM
04:30PM
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients' homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Bavaro Michael Chief Human Resources Officer Feb 28 '24 Sale 31.73 1,984 62,944 43,428 Mar 01 04:28 PM KRAEMER HARRY M JANSEN JR Director Feb 26 '24 Buy 31.55 35,000 1,104,352 269,528 Feb 28 04:41 PM RADEMACHER JOHN CHARLES Chief Executive Officer Feb 21 '24 Option Exercise 0.00 11,087 0 705,876 Feb 23 06:21 PM SHAPIRO MICHAEL H. Chief Financial Officer Feb 17 '24 Option Exercise 0.00 3,652 0 180,570 Feb 21 09:55 PM Bierbower Elizabeth D Director Oct 30 '23 Buy 26.37 3,000 79,110 13,515 Nov 01 05:09 PM Pate R Carter Director Aug 17 '23 Buy 34.32 1,465 50,279 106,112 Aug 21 05:08 PM Smyser Collin GC & Corporate Secretary Aug 14 '23 Buy 34.69 2,500 86,725 2,500 Aug 15 05:24 PM KRAEMER HARRY M JANSEN JR Director Aug 11 '23 Buy 34.63 55,000 1,904,518 234,528 Aug 15 05:26 PM Smyser Collin GC & Corporate Secretary May 19 '23 Option Exercise 0.00 812 0 16,623 May 22 04:08 PM
Index S&P 500
P/E 61.69
EPS (ttm) 2.32
Insider Own 1.21%
Shs Outstand 135.77M
Perf Week 2.07%
Market Cap 19.35B
Forward P/E 15.66
EPS next Y 9.14
Insider Trans -1.64%
Shs Float 133.57M
Perf Month 10.74%
Income 321.00M
PEG 6.53
EPS next Q 2.19
Inst Own 76.51%
Short Float 1.06%
Perf Quarter 27.61%
Sales 15.71B
P/S 1.23
EPS this Y 16.88%
Inst Trans -1.75%
Short Ratio 1.40
Perf Half Y 37.70%
Book/sh 31.52
P/B 4.54
EPS next Y 7.12%
ROA 2.47%
Short Interest 1.42M
Perf Year 77.07%
Cash/sh 5.52
P/C 25.91
EPS next 5Y 9.45%
ROE 7.41%
52W Range 76.58 - 143.35
Perf YTD 32.23%
Dividend Est. 1.54 (1.08%)
P/FCF 16.96
EPS past 5Y -17.61%
ROI 3.42%
52W High -0.16%
Beta 0.69
Dividend TTM 1.48 (1.03%)
Quick Ratio 1.24
Sales past 5Y 8.68%
Gross Margin 15.19%
52W Low 86.89%
ATR (14) 2.46
Dividend Ex-Date Jun 14, 2024
Current Ratio 1.35
EPS Y/Y TTM -51.92%
Oper. Margin 9.24%
RSI (14) 81.40
Volatility 2.34% 1.86%
Employees 47000
Debt/Eq 1.22
Sales Y/Y TTM 7.62%
Profit Margin 2.04%
Recom 1.65
Target Price 155.55
Option/Short Yes / Yes
LT Debt/Eq 1.21
EPS Q/Q 76.59%
Payout 101.25%
Rel Volume 0.50
Prev Close 142.62
Sales Surprise 4.10%
EPS Surprise 34.80%
Sales Q/Q 7.46%
Earnings Apr 30 BMO
Avg Volume 1.01M
Price 143.12
SMA20 9.54%
SMA50 10.65%
SMA200 31.04%
Trades
Volume 383,137
Change 0.35%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-05-24 Upgrade
Barclays
Equal Weight → Overweight
Nov-17-23 Upgrade
Argus
Hold → Buy
May-25-23 Upgrade
Wells Fargo
Equal Weight → Overweight
$87 → $102
Mar-27-23 Downgrade
Jefferies
Buy → Hold
$120 → $95
Dec-08-22 Initiated
Citigroup
Buy
$130
Aug-30-22 Initiated
RBC Capital Mkts
Sector Perform
$106
Jun-07-22 Downgrade
Barclays
Overweight → Equal Weight
$105
Mar-24-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$97 → $113
Mar-18-22 Resumed
Stifel
Buy
$126
Aug-20-21 Downgrade
Argus
Buy → Hold
May-21-21 Resumed
Citigroup
Buy
$120
May-13-21 Initiated
Wells Fargo
Overweight
$120
Apr-05-21 Upgrade
Goldman
Neutral → Buy
$111 → $116
Sep-23-20 Upgrade
Barclays
Equal Weight → Overweight
$109 → $110
Sep-22-20 Upgrade
JP Morgan
Neutral → Overweight
$115
Aug-21-20 Initiated
Evercore ISI
Outperform
May-07-20 Resumed
Credit Suisse
Outperform
$133
Apr-20-20 Upgrade
Citigroup
Neutral → Buy
$115
Mar-31-20 Initiated
William Blair
Outperform
Mar-03-20 Upgrade
Wells Fargo
Equal Weight → Overweight
$120
Show Previous Ratings
Today 11:18AM
09:30AM
09:00AM
08:00AM
May-06-24 12:20PM
06:28AM
Loading…
06:28AM
May-03-24 04:23PM
09:35AM
01:11AM
May-01-24 02:19PM
11:40AM
11:27AM
11:19AM
11:19AM
10:59AM
10:57AM
Loading…
10:57AM
10:57AM
10:27AM
09:15AM
08:00AM
07:24AM
03:03AM
Apr-30-24 04:41PM
10:55AM
10:40AM
09:30AM
09:28AM
09:26AM
07:32AM
06:41AM
06:04AM
Loading…
06:04AM
(Associated Press Finance)
06:00AM
Apr-26-24 05:50PM
04:15PM
Apr-24-24 06:00PM
01:27PM
09:00AM
Apr-23-24 10:00AM
Apr-19-24 09:30AM
Apr-18-24 06:00PM
Apr-17-24 09:40AM
Apr-15-24 08:00AM
Apr-12-24 06:00PM
02:48PM
Apr-11-24 12:10PM
09:45AM
09:40AM
Apr-09-24 08:00AM
Apr-08-24 06:15PM
Apr-05-24 11:48AM
Apr-02-24 08:00AM
Mar-29-24 08:00AM
Mar-28-24 08:00AM
Mar-26-24 09:45AM
Mar-25-24 10:15AM
Mar-22-24 09:50AM
Mar-21-24 10:41AM
Mar-20-24 08:00AM
08:00AM
Mar-18-24 01:55PM
Mar-15-24 10:10AM
Mar-14-24 11:30AM
Mar-11-24 08:32AM
Mar-07-24 04:00PM
Mar-06-24 09:50AM
08:00AM
Mar-05-24 12:00PM
08:00AM
Mar-04-24 08:00AM
Feb-28-24 09:40AM
Feb-23-24 02:05PM
Feb-22-24 11:29PM
Feb-21-24 02:55PM
Feb-16-24 02:31PM
Feb-15-24 08:00AM
Feb-14-24 11:52PM
02:22PM
09:09AM
12:28AM
(Thomson Reuters StreetEvents)
Feb-13-24 09:45AM
09:30AM
07:20AM
07:10AM
06:34AM
06:17AM
(Associated Press Finance)
06:17AM
06:00AM
Feb-12-24 09:40AM
Feb-08-24 04:15PM
04:00PM
09:31AM
09:15AM
08:00AM
Feb-06-24 10:00AM
Feb-02-24 09:40AM
Jan-30-24 07:07AM
Jan-29-24 04:30PM
08:00AM
Jan-25-24 12:10PM
Jan-22-24 08:00AM
Leidos Holdings, Inc. engages in providing services and solutions in the defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment provides services, solutions, and products focusing on digital modernization, mission systems and integration, command, control, computers, communications, intelligence, surveillance and reconnaissance technologies and services, maritime solutions, transformative software, analytics, intelligence analysis, mission support and logistics services, weapons systems and space systems and solutions. The Civil segment focuses on modernizing infrastructure, systems, and security. The Health segment offers solutions to federal and commercial customers that are responsible for the health and wellbeing of people worldwide including service members and veterans. The company was founded by John Robert Beyster on February 3, 1969 and is headquartered in Reston, VA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Fasano Gerard A Chief Growth Officer May 02 '24 Option Exercise 102.89 22,540 2,319,180 110,502 May 03 04:21 PM Kovarik Robert C JR Director May 02 '24 Option Exercise 70.64 3,879 274,013 11,481 May 03 04:12 PM SHAPARD ROBERT S Director May 02 '24 Option Exercise 52.70 4,788 252,328 55,000 May 03 04:09 PM STALNECKER SUSAN M Director May 02 '24 Option Exercise 52.70 4,788 252,328 19,536 May 03 04:15 PM KRAEMER HARRY M JANSEN JR Director May 02 '24 Option Exercise 52.70 4,788 252,328 89,065 May 03 04:18 PM STALNECKER SUSAN M Director May 02 '24 Sale 141.97 3,014 427,909 14,748 May 03 04:15 PM Kovarik Robert C JR Director May 02 '24 Sale 142.21 1,952 277,592 7,602 May 03 04:12 PM Fubini David G Director Mar 13 '24 Sale 127.89 7,874 1,006,969 14,696 Mar 14 06:18 PM Dahlberg Gregory R Director Feb 26 '24 Option Exercise 52.70 4,788 252,328 20,195 Feb 27 04:52 PM Hull Stephen Edward Sector President Feb 26 '24 Option Exercise 53.54 3,423 183,267 27,583 Feb 27 04:47 PM Geer Noel B Director Feb 22 '24 Option Exercise 52.70 4,788 252,328 29,925 Feb 23 05:18 PM May Gary Stephen Director Feb 21 '24 Option Exercise 52.70 4,788 252,328 16,140 Feb 22 04:59 PM May Gary Stephen Director Feb 21 '24 Sale 124.49 2,745 341,721 11,352 Feb 22 04:59 PM Porter Elizabeth A Sector President Feb 16 '24 Option Exercise 53.54 3,268 174,969 38,493 Feb 20 05:33 PM Fubini David G Director Feb 15 '24 Option Exercise 103.97 3,892 404,662 25,902 Feb 16 04:15 PM HOWE JERALD S JR EVP, General Counsel Feb 15 '24 Option Exercise 56.47 6,862 387,497 32,263 Feb 16 04:13 PM Cage Christopher R Chief Financial Officer Feb 15 '24 Option Exercise 53.54 2,774 148,520 37,729 Feb 16 04:11 PM MOHAPATRA SURYA N Director Nov 22 '23 Option Exercise 52.70 4,788 252,328 23,877 Nov 24 04:33 PM MOHAPATRA SURYA N Director Nov 22 '23 Sale 105.83 2,401 254,102 19,089 Nov 24 04:33 PM JOHN MIRIAM E Director Nov 16 '23 Sale 105.20 7,255 763,203 20,436 Nov 17 04:33 PM Fasano Gerard A Group President Nov 13 '23 Option Exercise 71.52 17,650 1,262,415 96,376 Nov 15 04:29 PM Fubini David G Director Nov 06 '23 Option Exercise 62.28 12,203 760,005 29,324 Nov 07 04:39 PM Geer Noel B Director Nov 06 '23 Sale 103.23 2,106 217,403 29,894 Nov 08 05:04 PM Moos James Robert Group President Nov 03 '23 Option Exercise 53.54 2,134 114,254 31,082 Nov 06 04:31 PM Moos James Robert Group President Nov 03 '23 Sale 103.66 564 58,464 28,948 Nov 06 04:31 PM Stevens Roy E Group President Nov 02 '23 Option Exercise 53.54 3,592 192,316 42,645 Nov 03 04:27 PM Stevens Roy E Group President Nov 02 '23 Sale 103.20 929 95,873 39,053 Nov 03 04:27 PM JOHN MIRIAM E Director Aug 10 '23 Option Exercise 39.70 5,193 206,162 29,805 Aug 14 04:41 PM SHAPARD ROBERT S Director Aug 04 '23 Option Exercise 39.70 5,193 206,162 52,308 Aug 04 04:44 PM KRAEMER HARRY M JANSEN JR Director Aug 04 '23 Option Exercise 39.70 5,193 206,162 89,470 Aug 07 04:38 PM KRAEMER HARRY M JANSEN JR Director Aug 04 '23 Sale 96.95 3,098 300,360 84,277 Aug 07 04:38 PM Bell Thomas Arthur CEO May 22 '23 Buy 78.81 6,300 496,502 6,300 May 22 04:42 PM STALNECKER SUSAN M Director May 12 '23 Option Exercise 39.70 5,193 206,162 17,382 May 15 04:15 PM May Gary Stephen Director May 11 '23 Option Exercise 39.70 5,193 206,162 16,545 May 12 04:30 PM May Gary Stephen Director May 11 '23 Sale 78.71 2,618 206,061 11,352 May 12 04:30 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite